Evolution of antithrombin (AT) and fibrinogen (Fg) levels during induction chemotherapy with L-asparaginase (Asp) in adult patients with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL). Clinical outcomes and use of coagulation supportive treatments: The CAPELAL study

被引：0
|
作者：
Hunault-Berger, M [1 ]
Gruel, Y [1 ]
Harousseau, JL [1 ]
Delain, M [1 ]
Maakaroun, A [1 ]
Bulabois, CE [1 ]
Witz, F [1 ]
Bernard, M [1 ]
Lafon, I [1 ]
Cornillon, J [1 ]
Ladouzi, A [1 ]
Tizon, A [1 ]
Padrazzi, B [1 ]
Tellier, Z [1 ]
Ifrah, N [1 ]
机构：
[1] CHU Angers, Dept Hematol, Angers, France
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4486
引用
收藏
页码：204B / 204B
页数：1
相关论文
共 17 条
  • [1] Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study
    Hunault-Berger, Mathilde
    Chevallier, Patrice
    Delain, Martine
    Bulabois, Claude-Eric
    Bologna, Serge
    Bernard, Marc
    Lafon, Ingrid
    Cornillon, Jerome
    Maakaroun, Abdallah
    Tizon, Alexandra
    Padrazzi, Bruno
    Ifrah, Norbert
    Gruel, Yves
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10): : 1488 - 1494
  • [2] Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
    Couturier, Marie-Anne
    Huguet, Francoise
    Chevallier, Patrice
    Suarez, Felipe
    Thomas, Xavier
    Escoffre-Barbe, Martine
    Cacheux, Victoria
    Pignon, Jean-Michel
    Bonmati, Caroline
    Sanhes, Laurence
    Bories, Pierre
    Daguindau, Etienne
    Dorvaux, Veronique
    Reman, Oumedaly
    Frayfer, Jamile
    Orvain, Corentin
    Lheritier, Veronique
    Ifrah, Norbert
    Dombret, Herve
    Hunault-Berger, Mathilde
    Tanguy-Schmidt, Aline
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 986 - 991
  • [3] Shift to Anti-Fibrinolysis on the Administration of L-Asparaginase (L-Asp) during Induction Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL)
    Ishihara, Takashi
    Nogami, Keiji
    Matsumoto, Tomoko
    Takeshita, Yasufumi
    Nomura, Akitaka
    Ochi, Satoshi
    Ishida, Toshiaki
    Kosaka, Yoshiyuki
    Sawada, Akihisa
    Inoue, Masami
    Shima, Midori
    BLOOD, 2016, 128 (22)
  • [4] INCIDENCE OF THROMBOTIC COMPLICATIONS IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA RECEIVING L-ASPARAGINASE DURING INDUCTION THERAPY - A RETROSPECTIVE STUDY
    GUGLIOTTA, L
    MAZZUCCONI, MG
    LEONE, G
    MATTIOLIBELMONTE, M
    DEFAZIO, D
    ANNINO, L
    TURA, S
    MANDELLI, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 49 (02) : 63 - 66
  • [5] ANTITHROMBIN-III INFUSION SUPPRESSES COAGULATION AND FIBRINOLYTIC HYPERACTIVATION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS RECEIVING ESCHERICHIA-COLI L-ASPARAGINASE - A GIMEMA STUDY
    MAZZUCCONI, MG
    GUGLIOTTA, L
    LEONE, G
    DESTEFANO, V
    DRAGONI, F
    BELMONTE, MM
    CHISTOLINI, A
    TURA, S
    MANDELLI, F
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 599 - 599
  • [6] A phase I study of eryaspase (L-asparaginase encapsulated in red blood cells) in combination with induction and consolidation chemotherapy for adult patients (pts) with newly diagnosed acute lymphoblastic leukemia (ALL)
    Walker, Alison
    Klisovic, Rebecca
    Rizzieri, David
    Emadi, Ashkan
    Kolitz, Jonathan
    Stock, Wendy
    Clancy, Daniel E.
    El Hariry, Iman
    Larson, Richard A.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Thromboembolism in adults with acute lymphoblastic leukemia (ALL) during induction with L-asparaginase (ASP)-containing multi-agent regimens: Incidence, risk factors, and possible role of antithrombin (AT) in pathogenesis and prophylaxis.
    Elliott, MA
    Wolf, RC
    Hook, CC
    Pruthi, RK
    Heit, JA
    Letendre, LL
    Tefferi, A
    Kaufmann, SH
    Mesa, RA
    Litzow, MR
    BLOOD, 2003, 102 (11) : 878A - 878A
  • [8] PEG L-asparaginase (PEG-ASP): Pharmacokinetics (PK) and clinical response in newly diagnosed adults with acute lymphoblastic leukemia (ALL) treated with multiagent chemotherapy.
    Douer, D
    Cohen, LJ
    Periclou, LA
    Watkins, K
    Levine, AM
    Avramis, VI
    BLOOD, 1997, 90 (10) : 1490 - 1490
  • [9] Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi Institutional Review
    Borate, Uma
    Hathaway, Amanda Redden
    Peker, Deniz
    Jackson, Bradford E.
    Kota, Vamsi K.
    Shah, Bijal D.
    Zhang, Ling
    Jillella, Anand
    Arellano, Martha
    Heffner, Leonard T.
    Erba, Harry P.
    BLOOD, 2015, 126 (23)
  • [10] Clinical activity of ERY001 (erythrocyte encapsulated l-asparaginase) and native l-asparaginase (L-ASP) in combination with COOPRALL regimen in phase III randomized trial in patients with relapsed acute lymphoblastic leukemia (ALL)
    Bertrand, Yves
    Baruchel, Andre
    Thomas, Xavier G.
    Blin, Nicolas
    Tardy, Emmanuelle Tavernier
    Perel, Yves
    Vey, Norbert
    Gandemer, Virginie
    Cacheux, Victoria
    Mazingue, Francoise
    Raffoux, Emmanuel
    Plat, Genevieve
    Poiree, Maryline
    Stephan, Jean-Louis
    Auvrignon, Anne
    Plantaz, Dominique
    Pellier, Isabelle
    Bonin, Cecile
    El-Hariry, Iman
    Ferster, Alina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12